<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/25335">
<title>Revista de Științe ale Sănătății din Moldova : Moldovan Journal of Health Sciences 2023 nr. 3(10)</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/25335</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/26372"/>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/26370"/>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/26369"/>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/26368"/>
</rdf:Seq>
</items>
<dc:date>2026-04-07T02:34:01Z</dc:date>
</channel>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/26372">
<title>Revista de Științe ale Sănătății din Moldova = Moldovan Journal of Health Sciences. 2023, Vol. 10(3)</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/26372</link>
<description>Revista de Științe ale Sănătății din Moldova = Moldovan Journal of Health Sciences. 2023, Vol. 10(3)
Revista de Științe ale Sănătății din Moldova (Moldovan Journal of Health Sciences) a fost lansată în octombrie 2014. Aceasta este editată în limbile română și engleză, conform standardelor și ghidurilor internaționale actuale în domeniul științelor medicale, și are o apariție trimestrială. Revista este înregistrată în Instrumentul Bibliometric Național IBN/IDSI (nr.1 din 16.11.2015), iar din 21 decembrie 2017, prin Hotărârea Consiliului Suprem pentru Știință și Dezvoltare Tehnologică nr. 169, a fost inclusă în lista revistelor științifice de Tip B. Revista este înregistrată în 2 baze de date internaționale.
</description>
<dc:date>2023-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/26370">
<title>Treatment of deep carious lesions with mineral trioxide aggregate: clinical case report</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/26370</link>
<description>Treatment of deep carious lesions with mineral trioxide aggregate: clinical case report
Trifan, Diana; Uncuța, Diana
Abstract. Introduction. Deep carious lesions are a dental disease widely spread among population of all ages. From clinical point of&#13;
view, they have little symptoms and go unnoticed by the patients a long time, until they provoke dental pulp inflammations.&#13;
If diagnosed and treated properly, the tooth can be treated conservatively with certain techniques of pulp vitality preservation. An important role in this process plays the innate capacity of regeneration of the pulp-dentine complex and the&#13;
enhanced stimulating properties of new biomaterials used in dentistry. The aim of this clinical case report is to describe the&#13;
clinical manifestations and the diagnostic algorithm used in deep caries and to establish a clinical guideline of treatment of&#13;
deep carious lesion with a calcium silicate hydraulic cement.&#13;
Material and methods. Description of clinical case of a permanent tooth with a deep carious lesion, treated by indirect&#13;
pulp capping with mineral trioxide aggregate cement. Clinical and paraclinical methods of investigations were used, the&#13;
patient was evaluated after 6 and 12 months after the received treatment.&#13;
Results. The sensitivity to cold stimuli presented by the patient before the treatment attenuated shortly after he received&#13;
dental care. After 6 and 12 months, the tooth is asymptomatic, the clinical findings and paraclinical parameters show no&#13;
evidence of pulp inflammation.&#13;
Conclusions. Mineral trioxide aggregate showed long term successful results when used as a biomaterial for vital pulp&#13;
therapy.
</description>
<dc:date>2023-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/26369">
<title>Laser ureteroscopic endopyelotomy efficacy in pyeloureteral junction stenosis</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/26369</link>
<description>Laser ureteroscopic endopyelotomy efficacy in pyeloureteral junction stenosis
Caraion, Vladimir; Pleșca, Eduard; Mezu, Andrei; Maximciuc, Corneliu
Abstract. Introduction. Pyeloureteral junction stenosis (PUJS) is a condition that affects urinary drainage at level of the renal pelvis&#13;
and upper ureter. It is found in approximately 1 in 500 newborns, with a higher prevalence in males (2:1 ratio). PUJS is the&#13;
main cause of congenital hydronephrosis and can also be caused by other specific pathologies. Endoscopic management is the&#13;
primary treatment for PUJS, particularly in cases of aperistaltic and &lt;2cm intrinsic ureteral stenosis without aberrant vessels.&#13;
Aim of the study. Efficacy assessment of endoscopic retrograde incision of PUJS for urinary drainage recovery and duration of postoperatory effect.&#13;
Material and methods. 5 patients were operated, from November 2022 to February 2023. Each patient has been operated by using retrograde LASER endopyelotomy method. There were excluded patients with extrinsic ureteral obstruction,&#13;
defected segment more than 2 cm, massive hydronephrosis, split renal function &lt;20%, tumor in the obstruction area, high&#13;
ureteral insertion, patients &lt;18 years of age. Mean follow-up time of patients is 8 weeks.&#13;
Results. One month after intervention patients were recalled for investigations. There were observed way more better&#13;
results in the patients with grade 1 hydronephrosis than those with grade 2 (p = 0.002). All patients at 3-month postoperative follow-up reported resolution of symptoms.&#13;
Conclusions. Efficacy of LASER endopyelotomy is 99.9% in first months of the follow-up, after double J stent extraction.&#13;
More follow-up time and patients are required to present more statistically significant results.
</description>
<dc:date>2023-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/26368">
<title>The role of the lateral pterygoid muscle in temporomandibular disorders</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/26368</link>
<description>The role of the lateral pterygoid muscle in temporomandibular disorders
Pântea, Vitalie; Tabără, Felicia; Ceban, Mariana; Burduja, Veronica; Nistor, Lilian; Ursu, Olga
Abstract. Introduction. The clinical concept that would argue that the activity of the lateral pterygoid muscle, being disturbed, would&#13;
play an important role as an etiological factor in temporomandibular joint dysfunctions is still widely accepted, being also&#13;
a decisive factor in the correct choice of the treatment plan. However, because of the fact that very few research and clear&#13;
evidence were conducted and presented to support completely that concept, it continues to remain a very controversial one.&#13;
Material and methods. For this literature review were considered and studied scientific articles published between 2000&#13;
and 2023, in the following electronic databases: PubMed, MEDLINE, Google Scholar, BIR Publications, ScienceDirect. Research methods – analysis, synthesis, systematization, and description.&#13;
Results. Patients presenting temporomandibular joint dysfunction complain about pain in the temporomandibular joint&#13;
or/and in masticatory muscles, limitation and sounds during mandibular activity. Temporomandibular dysfunction is a&#13;
non-specific collective term, used to describe a heterogeneous group of pathological conditions located in the territory of&#13;
the stomatognathic system. These are considered musculoskeletal conditions that cause pain while performing the function (mastication, speech, swallowing), with increased sensitivity in the masticatory muscles and/or the temporomandibular joint, with possible limitations of the range of motion, the appearance of joint noises and otological symptoms. One of&#13;
the theories claims that in temporomandibular dysfunction, the lateral pterygoid muscle becomes hyperactive, hypoactive&#13;
or that there is a lack of coordination between the superior and inferior branches of the muscle, or that there is a disturbance during the performance of the role of the muscle to control and stabilize the temporomandibular joint. However,&#13;
the in-depth study of the specialized literature indicates that no scientific evidence is yet available that the function of the&#13;
lateral pterygoid muscles in temporomandibular dysfunction is somehow disturbed. Moreover, the muscle’s role during&#13;
the execution of its normal function has also been questioned and remains a matter of controversy.&#13;
Conclusions. The lateral pterygoid muscle obviously plays an important role in the development of temporomandibular&#13;
dysfunction through the prism of its anatomical and functional particularities, referring to the superior fascicle responsible&#13;
for the correct anatomical maintenance of the articular disc during function.
</description>
<dc:date>2023-01-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
